Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

Comparison of Nonfasting and Fasting Lipoprotein Subfractions and Size in 15,397 Apparently Healthy Individuals: An Analysis from the VITamin D and OmegA-3 TriaL (VITAL)

(2020) Zareen M. Farukhi et al.   Journal of Clinical Lipidology

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease

(2020) Alan Chait et al.   DIABETES

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

(2020) Edward K. Duran et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Causes and Consequences of Hypertriglyceridemia

(2020) Chris J. Packard et al.   Frontiers in Endocrinology

Remnant lipoproteins

(2020) Carlos A. Aguilar Salinas et al.   CURRENT OPINION IN LIPIDOLOGY

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies

(2020) Brian Olshansky et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

(2019) Brian A. Ference et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

(2019) Anette Varbo et al.   ANNALS OF NEUROLOGY

Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014

(2019) Wenjun Fan et al.   DIABETES CARE

Clinical review on triglycerides

(2019) Ulrich Laufs et al.   EUROPEAN HEART JOURNAL

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

(2019) Michel R. Langlois et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

(2019) E. Björnson et al.   JOURNAL OF INTERNAL MEDICINE

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial

(2018) Antonio J. Vallejo-Vaz et al.   CIRCULATION

Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence - Prospective Data from the Women's Health Study

(2018) Aaron W. Aday et al.   CIRCULATION

Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke

(2018) Michael V. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease

(2018) Anum Saeed et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

(2018) Aruna D. Pradhan et al.   AMERICAN HEART JOURNAL

Low-Grade Inflammation in the Association Between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population

(2018) Signe E. J. Hansen et al.   CLINICAL CHEMISTRY

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

(2018) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease

(2018) A.David Marais   PATHOLOGY

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol

(2017) Patrick R. Lawler et al.   Journal of the American Heart Association

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies

(2016) Parag H. Joshi et al.   Journal of the American Heart Association

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

(2016) Geesje M. Dallinga-Thie et al.   Current Cardiology Reports

Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population

(2015) A. Varbo et al.   CLINICAL CHEMISTRY

Mendelian randomization of blood lipids for coronary heart disease

(2014) Michael V. Holmes et al.   EUROPEAN HEART JOURNAL

Common variants associated with plasma triglycerides and risk for coronary artery disease

(2013) Ron Do et al.   NATURE GENETICS

Postprandial lipoproteins and the molecular regulation of vascular homeostasis

(2013) Kathleen M. Botham et al.   PROGRESS IN LIPID RESEARCH

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects

(2011) Marja-Riitta Taskinen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis

(2011) Meng Lee et al.   ATHEROSCLEROSIS

Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis

(2011) Eric A. Schwartz et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Recent insights into factors affecting remnant lipoprotein uptake

(2010) Kevin Jon Williams et al.   CURRENT OPINION IN LIPIDOLOGY

Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis

(2010) Eric Bruckert et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women

(2009) Samia Mora et al.   CIRCULATION

Limitations of Automated Remnant Lipoprotein Cholesterol Assay for Diagnostic Use

(2009) E. J. Schaefer   CLINICAL CHEMISTRY

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

(2008) R. Scott et al.   DIABETES CARE

Ethnic differences in the ability of triglyceride levels to identify insulin resistance

(2007) Anne E. Sumner et al.   ATHEROSCLEROSIS